Goal Directed Fluid Therapy in Free Flap Reconstructive Surgery
- Conditions
- Head and Neck Cancer
- Interventions
- Other: Goal directed fluid management based on continuous monitoring of stroke volume
- Registration Number
- NCT01129037
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
Wide excision of head and neck cancer with microsurgical free flap's reconstruction (FFR) results to a high cancer cure rate and a good functional recovery. However, this long complex procedure is accompanied with considerable complications. Excessive fluid administration during this type of surgery has been connected with poor results. There is growing evidence that goal-directed fluid management (GDFM) might improve the results in high-risk patients.
Hypothesis: Goal directed fluid management will reduce intraoperative fluid volume administered to patients undergoing head and neck reconstructive surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
- Age 18-80 years
- Signed informed consent
- History CHF
- Severe valvular heart defects, intra cardiac shunts
- Irregular heart rhythm
- Allergy to hydroxyethyl starch solutions
- Coagulation abnormalities (INR>1.5, aPTT>40s, platelet count<100x10 9/L
- History of severe bleeding disorders
- Renal insufficiency with creatinine >200Umol/L
- Pregnant of nursing women
- History of skin disorders that are accompanied by chronic puritis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Goal directed fluid management Goal directed fluid management based on continuous monitoring of stroke volume -
- Primary Outcome Measures
Name Time Method The volume of fluid administered intraoperatively during reconstructive surgery for head and neck oncology Initiation of surgery to end of surgery on average 8-10 hours
- Secondary Outcome Measures
Name Time Method Incidence of major complication and LOS Post operative day 0 to hospital discharge Cardiovascular, respiratory, neurologic, thromboembolic, renal,liver, GI, sepsis,and surgical complications willl be recorded
Trial Locations
- Locations (1)
Toronto General Hospital, UHN
🇨🇦Toronto, Ontario, Canada